---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-25-001033"
form_type: "8-K"
ticker: "AVXL"
cik: "0001314052"
company_name: "ANAVEX LIFE SCIENCES CORP."
filed_at: "2025-07-28T23:59:59+00:00"
generated_at: "2026-05-18T00:09:29.072916+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Anavex Life Sciences enters $150M at-the-market equity facility with TD Securities

## Summary
- Sales agreement with TD Securities (USA) LLC for ATM offering of up to $150M in common stock.
- Shares sold under shelf registration statement filed July 14, 2025, effective July 23, 2025.
- Sales agent commission up to 3.0% of gross proceeds; company not obligated to sell any shares.
- Sales may be conducted on Nasdaq or in negotiated transactions; offering can be suspended by either party.

## SEC filing metadata
- accession: 0001731122-25-001033
- form_type: 8-K
- ticker: AVXL
- cik: 0001314052
- company_name: ANAVEX LIFE SCIENCES CORP.
- filed_at: 2025-07-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1314052/000173112225001033/0001731122-25-001033-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1314052/000173112225001033/e6735_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-25-001033
- JSON: https://secwatch.observer/filing/0001731122-25-001033.json
- Plain text: https://secwatch.observer/filing/0001731122-25-001033.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.